A structural insight into CK2 inhibition

Marco Mazzorana1, Lorenzo A Pinna, Roberto Battistutta

  • 1Department of Biological Chemistry, University of Padua, Padua, Italy.

Insights

Protein kinase CK2, a target for cancer therapy, has unique features making it drug-resistant. New inhibitors targeting its ATP-binding site show promise by exploiting hydrophobic interactions and conserved water molecules for selective binding.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • The Ser/Thr protein kinase CK2 is a pleiotropic enzyme with constitutive activity.
  • CK2 plays crucial roles in normal cellular processes, including cell survival.
  • CK2 also contributes to tumor progression, making it a significant therapeutic target.

Purpose of the Study:

  • To review recent studies on inhibitors targeting the CK2 ATP-binding site.
  • To highlight the unique features of CK2, such as its ability to use both ATP and GTP and resistance to staurosporine.
  • To discuss the binding characteristics and selectivity of various chemical inhibitor families.

Main Methods:

  • Analysis of CK2 crystal structures.
  • Investigation of inhibitor binding to the CK2 ATP-binding site.
  • Evaluation of inhibitor potency and selectivity.

Main Results:

  • Selective inhibitors with nanomolar to low micromolar potency were identified.
  • Hydrophobic interactions with the CK2 binding cleft are a key binding contributor.
  • Conserved water molecules near Lys68 and bulky residues (Ile66, Ile174) influence ligand orientation and selectivity.

Conclusions:

  • CK2 inhibitors can be developed by targeting the ATP-binding site.
  • Understanding the structural features of the active site is critical for designing selective inhibitors.
  • These findings provide a basis for developing novel CK2-targeted therapeutics.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...